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Abstract
Objective The aim of this study was to create a new
template for the anatomical normalization of I-123 FP-CIT
SPECT images of Japanese people to evaluate dopamine
transporter binding.
Methods The subjects consisted of 16 normal control
subjects (5 females and 11 males; mean age ± SD,
51.6 ± 9.5 years, ranging from 25 to 62 years) and 21
parkinsonian patients (7 females and 14 males; mean
age ± SD, 70.7 ± 9.4 years, ranging from 49 to 85 years).
All normal control subjects and 21 patients with parkin-
sonism underwent MRI. A total of 148 MBq of I-123 FP-
CIT was intravenously injected as a bolus, and a SPECT
scan was started 4 h later. Data were analyzed with the
Statistical Parametric Mapping 8 (SPM8) software. At first,
I-123 FP-CIT SPECT images were co-registered to MRI
images and MRI images were normalized to Montreal
Neurological Institute (MNI) space using a gray.nii tem-
plate. Co-registered I-123 FP-CIT SPECT images were
normalized using the predetermined normalization param-
eters for MRI images. Then, anatomically normalized
I-123 FP-CIT SPECT images were divided by background
counts individually measured using ROIs set on the cere-
bral cortices. The I-123 FP-CIT template was created by
averaging the normalized SPECT images of the 16 normal
control subjects. Thereafter, the averaged MRI images of
the 16 normal control subjects were also created.
Results A visual inspection revealed that there were no
apparent differences between the I-123 FP-CIT images
subjected to the two methods of anatomical normalization
in normal control subjects. However, a group comparison
by a paired t test using SPM8 revealed that the I-123 FP-
CIT binding was significantly higher in the substriatal and
temporal regions in I-123 FP-CIT images directly nor-
malized with the I-123 FP-CIT template than in those
normalized by the predetermined parameters with MRI,
while it was higher in the bilateral frontal cortical regions
in the latter than in the former images.
Conclusion We successfully created an I-123 FP-CIT
template for Japanese people. This template is thought to
be useful and reliable for the statistical analysis of I-123
FP-CIT images, although some problems exist in the
evaluation of parkinsonian patients. The results of a paired
t test using SPM suggest that we should use the same
normalization method in statistical image analyses.
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Introduction
I-123 FP-CIT (I-123 Ioflupane, DaTSCAN) is a ligand for
evaluating striatal dopamine transporter imaging that is
mainly localized in the presynaptic dopaminergic neurons
of the striatum, which consists of the caudate nucleus and
the putamen [1, 2]. The striatal level of dopamine trans-
porters decreases in Parkinson’s disease or dementia with
Lewy bodies, while it is preserved in essential tremor or
vascular parkinsonism [3, 4]. Therefore, I-123 FP-CIT is
widely used for the differential diagnosis of dementia and
parkinsonism [5]. The striatum is a relatively small struc-
ture, and is easily rotated by mispositioning or a patient’s
movement. For this reason, setting ROIs manually may
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cause interobserver error [6]. The anatomical normalization
of I-123 FP-CIT SPECT images can correct such misreg-
istration and makes it easy to interpret the images. In
addition, quantitative information, such as the specific to
non-specific binding ratio, is easily obtained using ROIs set
on anatomically normalized SPECT images [6]. Statistical
Parametric Mapping (SPM) (Wellcome Department of
Imaging Neuroscience, Institute of Neurology, University
College London) is one of the most reliable softwares for a
voxel-based statistical image analysis [7]. In the SPM
analysis, a specific template for each ligand is needed for
the anatomical normalization of the brain images [8].
However, a template for I-123 FP-CIT has not yet been
prepared in SPM. Thus, we created a new template using
I-123 FP-CIT and a high-resolution SPECT device for
Japanese people, and compared the results between two
normalization techniques, namely, FP-CIT template-based
and MRI-based methods.
Subjects and methods
The subjects consisted of 16 normal control subjects (5
females and 11 males; mean age ± SD, 51.6 ± 9.5 years,
ranging from 25 to 62 years) and 21 parkinsonian patients (7
females and 14 males; mean age ± SD, 70.7 ± 9.4 years,
ranging from 49 to 85 years). All of the normal control
subjects were medical staff members who underwent both
I-123 FP-CIT SPECT and MRI studies, and none of them
showed either any neurological symptoms or an organic
brain lesions, such as cerebral infarct onMRI, although three
of them were found to have small white matter lesions. The
parkinsonian patients were retrospectively selected, and they
all underwent both I-123 FP-CIT SPECT and MRI studies,
while including 11 patients with Parkinson’s disease, 3
patients with multisystem atrophy, 2 patients with secondary
parkinsonism, 2 patients with progressive supranuclear
palsy, 1 patient with dementia with Lewy body disease and 2
patients with parkinsonism of an unknown etiology.
In the SPECT studies, 148 MBq of I-123 FP-CIT was
intravenously injected for about 20 s, and the SPECT scan
was started 4 h later using a three-head gamma camera
(Toshiba GCA-9300R), with a high-resolution fan beam
collimator. The intrinsic and system resolution were 3.8 mm
and 9.0 mm in FWHM, respectively. Data were collected for
20 min in a 128 9 128 matrix (120 rotation, 30 views, 5 s
per projection), and then were reconstructed using a 3D-
OSEM algorithm (iteration 4 and subset 15) without scatter
correction. Attenuation correction was performed using a l
value of 0.06. The order and cut-off frequency of the But-
terworth filter were 4 and 0.13 cycles, respectively.
MRI studies were performed using Intera Achieva
(1.5 T, Phillips Co. Ltd.) or Discovery MR750w (3 T, GE
Co. Ltd.). Three-dimensional brain images were obtained
in the sagittal plain of a 240-mm field of view in a
256 9 256 matrix in both machines, and reconstructed for
a voxel size of 0.75 9 0.94 9 0.94 mm3 on 1.5 T and
1.20 9 0.94 9 0.94 mm3 on 3 T, respectively.
Prior to the data analyses, both SPECT and MRI images
were converted to the analyze format from the DICOM
format using theMRIcro software, and then the sagittal MRI
images were rearranged in the axial plain. A statistical image
analysis was performed with SPM8 according to the method
shown in Fig. 1. I-123 FP-CIT images were initially co-
registered and resliced to MRI images. To determine the
parameters for the anatomical normalization, MRI images
were segmented into the gray and white matter, and then the
graymatter images were normalized to the grey.nii template.
The I-123 FP-CIT images co-registered to the corresponding
MRI images were also normalized using the individually
predetermined normalization parameters. After that, the
radioactivity counts of the I-123 FP-CIT images were nor-
malized using the background counts measured using three-
dimensional ROIs set on cortical areas of the MRI images in
order to measure the non-specific binding of I-123 FP-CIT
(Fig. 2). The I-123 FP-CIT template was created by aver-
aging the images of 16 normal control subjects. Finally, all
original I-123 FP-CIT images were anatomically normalized
using the I-123 FP-CIT template. To validate this direct
normalization using the I-123 FP-CIT template, we com-
pared it with the normalization by predetermined parameters
with MRI using both the visual inspection of superimposed
I-123 FP-CIT images on MRI and the statistical image
analysis using SPM8.
The study protocol was approved by the ethics com-
mittee/institutional review board of our hospital.
Results
I-123 FP-CIT template images are shown in Fig. 3. Figure 4
shows averagedMRI images of normal control subjects, I-123
FP-CIT images anatomically normalized by predetermined
parameters with MRI gray matter images (MRI-based
method) and I-123 FP-CIT images directly normalized with
the I-123 FP-CIT template (FP-CIT template-based method).
The latter two sets of I-123 FP-CIT images are displayed
superimposed on MRI images. A visual inspection revealed
that these superimposed I-123 FP-CIT imageswerewell fitted
to the MRI images, and there was no apparent difference
between them. Figure 5 shows the results of a group com-
parison by a paired t test between the averaged I-123 FP-CIT
images anatomically normalized by the MRI-based method
and the I-123 FP-CIT images directly normalized by the FP-
CIT template-based method. There were small differences
between the two normalization methods in the striatal, brain
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stem and cerebellar regions. Figure 6 shows averaged MRI
images of parkinsonian patients, I-123 FP-CIT images
anatomically normalized by theMRI-basedmethod and I-123
FP-CIT images directly normalized by the FP-CIT template-
based method. The latter two sets of I-123 FP-CIT images are
displayed superimposed on MRI images of parkinsonian
patients. A visual inspection revealed that the striatal
radioactivity slightly shifted to the bottom of the brain in the
FP-CIT template-based method compared to that in the MRI-
basedmethod. The results of a group comparison by a paired t
test are shown in Fig. 7. The I-123 FP-CIT binding was sig-
nificantly higher in the sub-striatal and temporal regions in
I-123 FP-CIT images directly normalized by the FP-CIT
template-based method than in those normalized by the MRI-
based method, while it was higher in the bilateral frontal
cortical regions in the latter than in the former.
Discussion
The anatomical normalization of brain images is very
useful for the clinical practice in nuclear medicine as well
as brain research. SPM is one of the most widely used
software for statistical image analyses [6, 10]. However, a
template for I-123 FP-CIT has not yet been prepared in
SPM. Thus, we created a new template for a statistical
image analysis of I-123 FP-CIT images using SPM8 and
high-resolution SPECT. To the best of our knowledge,
Fig. 1 Method of creating an
I-123 FP-CIT template using
MRI
Fig. 2 Three-dimensional T1-
WI (a) and ROI (b)
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there have been no reports on an I-123 FP-CIT template for
Japanese people.
I-123 FP-CIT accumulates mainly in the striatum, which
is the specific binding site of the dopamine transporter,
while the radioactivity of non-specific binding sites, such
as cerebral cortical regions, is very low [11, 12]. Thus, it is
expected that there are some difficulties in the co-regis-
tration of I-123 FP-CIT images to MRI.
Fig. 3 I-123 FP-CIT template images created from 16 normal control subjects
Fig. 4 Averaged MRI images of normal control subjects (a), I-123
FP-CIT images normalized by the MRI-based method (b) and I-123
FP-CIT images directly normalized by the FP-CIT template-based
method (c). The latter two sets of I-123 FP-CIT images are displayed
superimposed on MRI images
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There have been several studies on the creation of
templates for I-123 FP-CIT. Kas et al. [9] used SPM99
and an MNI-based template of 11C-raclopride for nor-
malization because of its high specific striatal binding and
low cortical uptake, which is similar to the profile of
I-123 FP-CIT images. Garcia-Go´mez et al. [13] normal-
ized I-123 FP-CIT images using the template for magnetic
resonance in T1-weighted sequences available in SPM5.
The updated templates are open on the website by this
group (http://www.nitrc.org/projects/spmtemplates), and
can be used for SPM analysis of F-18 DOPA PET and
I-123 FP-CIT SPECT. Although the spatial resolution is
lower than that of our template. Colloby et al. [14] con-
structed a template by averaging 33 subjects and trans-
formed them into the standard MNI space by
multimodality co-registration to a high-resolution T1 MR
image in standard MNI space. However, these studies
directly normalized I-123 FP CIT images using templates
for other tracers, and then created a template specific for
I-123 FP-CIT.
Fig. 5 The results of a group comparison by a paired t test between averaged I-123 FP-CIT images anatomically normalized by the MRI-based
method and the FP-CIT template-based method
Fig. 6 Averaged MRI images of parkinsonian patients (a), I-123 FP-
CIT images normalized by the MRI-based method (b) and I-123 FP-
CIT images directly normalized by the FP-CIT template-based
method (c). The latter two sets of I-123 FP-CIT images are displayed
superimposed on MRI images of parkinsonian patients
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In the present study, we created a template by using
MRI-aided spatial normalization. This technique has been
applied to a F-18 FDG template by Gispert et al. [15] and a
C-11-raclopride template by Meyer et al. [16]. Although
MRI-aided spatial normalization requires MRI images of
each subject for the creation of a template, this method is
considered more accurate than the one performed by using
only functional images [15, 16]. In the present study, we
could accurately co-register I-123 FP-CIT images to MRI
using SPM8, as shown in Fig. 3. There were no subjects in
whom the co-registration failed. However, in our experi-
ence, SPM2 sometimes failed in the anatomical normal-
ization (data not shown), as described elsewhere [9].
In addition, we revealed a difference in the results
between the two anatomical normalization methods using
SPM8. The use of an I-123 FP-CIT template makes it easy
to normalize the individual I-123 FP-CIT to MNI space
without co-registration to MRI. As shown in Fig. 4, a visual
inspection of I-123 FP-CIT images superimposed on MRI
images demonstrated no apparent difference between the
two normalization methods in normal control subjects.
However, the striatal radioactivity slightly shifted to the
bottom of the brain in the FP-CIT template-based method
compared to that in the MRI-based method in the group of
parkinsonian patients (Fig. 6). In addition, an SPM analysis
by a paired t test revealed a significant difference between
the two normalization methods, especially in the group of
parkinsonian patients. The reason for this difference is
speculated to be that a minimal co-registration or normal-
ization error affected the results. In addition, cerebral atro-
phy may cause a normalization error, which is more likely in
the case of parkinsonian patients who show mild cerebral
atrophy on MRI. In the group of parkinsonian patients, the
mean age was higher than in the normal control group. As
the striatal dopamine transporters decrease with aging [17],
the I-123 FP-CIT template would ideally be created using
age-matched control subjects. However, it is challenging to
create templates for different age groups, and the use of
various templates may cause an error in the results of SPM
analyses. The results of this study are thought to be rea-
sonable, and suggest that we should use the same normal-
ization method in SPM analyses.
Conclusion
We successfully created an I-123 FP-CIT template for
Japanese people. This template is thought to be useful and
reliable for the statistical image analysis of I-123 FP-CIT
images, although some problems exist in the evaluation of
parkinsonian patients.
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